| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.31 | 09 Dec 2025 | Direct |
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 5 | $0 | 4 | Director | 09 Dec 2025, 10:17 |
| AKRO | Akero Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:05 |
| AKRO | Akero Therapeutics, Inc. | 08 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 17:20 |
| AKRO | Akero Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 27 Jun 2023, 17:58 |
| AKRO | Akero Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:06 |
| AKRO | Akero Therapeutics, Inc. | 12 Jul 2021 | 1 | $0 | 4 | Director | 14 Jul 2021, 16:09 |
| AKRO | Akero Therapeutics, Inc. | 12 Jul 2021 | 0 | $0 | 3 | Director | 14 Jul 2021, 16:08 |